Key facts
- This page summarizes Faraz Ali's Form 4 filing for Tenaya Therapeutics, Inc. (TNYA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Nov 2026, 20:18.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Footnote F1
The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025. Such sales were automatic and not at the discretion of the Reporting Person.
Footnote F2
Includes 375,463 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.